GENELUX Corp
GNLX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001231457
In the last 90 days, GENELUX Corp insiders filed 0 open-market purchases and 6 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $29.5M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding GENELUX Corp changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 57 | 1 | 58 | +2 |
| Shares | 5.23M | 38.9K | 4.87M | −318.5K (−6.1%) |
| Value | $12.4M | $92.1K | $11.5M | −$787.5K (−6.4%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held GENELUX Corp at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Creative Planning | 43,025 | $101.5K | 0.00% |
| D.A. Davidson & Co. | 21,779 | $51.4K | 0.00% |
| Raymond James Financial Inc | 17,250 | $40.7K | 0.00% |
| Virtu Financial LLC | 10,454 | $25.0K | 0.00% |
| Centaurus Financial, Inc. | 10,000 | $24.0K | 0.00% |
| Beacon Capital Management, LLC | 9,566 | $22.6K | 0.00% |
| Prudent Man Investment Management, Inc. | 660 | $1.56K | 0.00% |
| BNP Paribas Arbitrage, SA | 407 | $961 | 0.00% |
| MAI Capital Management | 285 | $673 | 0.00% |
Sold out (7)
Institutions that held GENELUX Corp at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Affinity Asset Advisors, LLC | 100,000 | $237.0K |
| D. E. Shaw & Co., Inc. | 55,012 | $130.4K |
| Susquehanna International Group, LLP | 41,432 | $98.2K |
| Clearstead Advisors, LLC | 29,970 | $71.0K |
| XTX Topco Ltd | 24,693 | $58.5K |
| Qube Research & Technologies Ltd | 12,579 | $29.8K |
| Catalyst Funds Management Pty Ltd | 4,800 | $11.4K |
Not filed for Q4 2024 yet (1)
Institutions that held GENELUX Corp at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James Financial Services Advisors, Inc. | 38,856 | $92.1K |